| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.075 | 0.09 |